MedPath

A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)

Not Applicable
Completed
Conditions
Actinic Keratoses
Interventions
Procedure: Photodynamic therapy with methyl aminolevulinate
Registration Number
NCT00711178
Lead Sponsor
Bispebjerg Hospital
Brief Summary

A randomised, multi-center study of daylight mediated photodynamic therapy (PDT) with Metvix in patients with multiple actinic keratosis on the face and/or scalp.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • 18 years and older, 5 AK in face and scalp
Exclusion Criteria
  • immunosuppression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
APhotodynamic therapy with methyl aminolevulinate2 hours sunlight
BPhotodynamic therapy with methyl aminolevulinate3 hours of sunlight
Primary Outcome Measures
NameTimeMethod
response rate3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath